With the expertise of Inotiv’s scientists and dedication to the 3Rs, we collaborate with you to perform customized studies that meet your unique drug development needs, while minimizing the number of study subjects. Our AAALAC-accredited laboratories are built for purpose and support discovery through GLP regulatory studies using all common research models.
Throughout your project, strong lines of communication promote your success, with study design, conduct, and data interpretation that exceed your expectations. We are large enough to provide the experience and resources to complete your projects expertly and on time, while remaining flexible, accessible, and responsive to your needs.
Obtain high-quality data with lead optimization and candidate selection studies to evaluate tolerability, pharmacology, and DMPK parameters.
We support molecules of all classes, from small molecules and biologics to gene and cellular therapeutics.
When it benefits your study, your Inotiv team will develop fit-for-purpose, cost-effective, non-routine models of disease. Unique models we have developed to focus on specific targets of interest include:
From acute tolerability through multi-year and multi-generational safety assessments, we provide a consultative, responsive experience. You will receive timely and reliable reports that meet or exceed regulatory guidelines. For over 40 years, Inotiv’s experienced and proven safety assessment teams have backed thousands of successful IND and NDA/BLA submissions. In addition to routine protocols, our flexible, fast, and responsive team routinely develops custom protocols to meet our clients’ challenges. Our GLP toxicology services are comprehensive. Along with the in vivo conduct, we also provide:
Copyright © 2024 Inotiv. All Rights Reserved.